Sivia Capital Partners LLC Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Sivia Capital Partners LLC acquired a new stake in DENTSPLY SIRONA Inc. worth approximately $389,000 by purchasing 24,481 shares in the second quarter.
• DENTSPLY SIRONA's most recent earnings report showed a quarterly EPS of $0.52, beating expectations and reflecting a revenue of $936 million, although the revenue was down 4.9% compared to the previous year.
• The company announced a quarterly dividend of $0.16 per share, which translates to an annualized yield of 4.8%, with the ex-dividend date set for September 26th.

Sivia Capital Partners LLC bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 24,481 shares of the medical instruments supplier's stock, valued at approximately $389,000.

Several other large investors have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after acquiring an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock valued at $208,590,000 after acquiring an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of DENTSPLY SIRONA by 4.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier's stock valued at $180,445,000 after acquiring an additional 538,531 shares during the period. AQR Capital Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 119.4% during the first quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier's stock worth $93,423,000 after purchasing an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. lifted its holdings in shares of DENTSPLY SIRONA by 26.4% during the first quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier's stock worth $43,526,000 after purchasing an additional 609,300 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Barrington Research decreased their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a report on Friday, August 8th. Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a report on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Trading Down 1.9%

NASDAQ:XRAY traded down $0.26 during mid-day trading on Friday, reaching $13.16. The company's stock had a trading volume of 6,019,803 shares, compared to its average volume of 3,002,555. The company's fifty day simple moving average is $14.50 and its two-hundred day simple moving average is $14.94. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.44. The stock has a market cap of $2.63 billion, a P/E ratio of -2.78, a P/E/G ratio of 0.84 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same period last year, the company earned $0.49 EPS. The firm's quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.